Therapeutic Targets in Cancer Cell Metabolism and Autophagy

Overview

Journal Nat Biotechnol

Specialty Biotechnology

Date 2012 Jul 12

PMID 22781696

Citations 178

Authors

Heesun Cheong

Chao Lu

Tullia Lindsten

Craig B Thompson

Affiliations

Soon will be listed here.

Abstract

The metabolism of cancer cells is reprogrammed both by oncogene signaling and by dysregulation of metabolic enzymes. The resulting altered metabolism supports cellular proliferation and survival but leaves cancer cells dependent on a continuous supply of nutrients. Thus, many metabolic enzymes have become targets for new cancer therapies. Recently, two processes—expression of specific isoforms of metabolic enzymes and autophagy—have been shown to be crucial for the adaptation of tumor cells to changes in nutrient availability. An increasing number of approved and experimental therapeutics target these two processes. A better understanding of the molecular basis of cancer-associated metabolic changes may lead to improved cancer therapies.

Citing Articles

Current Understanding of the Role of Autophagy in the Treatment of Myeloid Leukemia.

Kubota Y, Kimura S Int J Mol Sci. 2024; 25(22).

PMID: 39596291 PMC: 11594995. DOI: 10.3390/ijms252212219.

Adaptations in glutathione-based redox protein signaling pathways and alcohol drinking across species.

Womersley J, Obellianne C, Padula A, Lopez M, Griffin W, Ball L Biomed Pharmacother. 2024; 180:117514.

PMID: 39362067 PMC: 11775667. DOI: 10.1016/j.biopha.2024.117514.

Senescence and senolysis in cancer: The latest findings.

Imawari Y, Nakanishi M Cancer Sci. 2024; 115(7):2107-2116.

PMID: 38641866 PMC: 11247613. DOI: 10.1111/cas.16184.

The multiple roles of autophagy in uveal melanoma and the microenvironment.

Liu B, Yao X, Shang Y, Dai J J Cancer Res Clin Oncol. 2024; 150(3):121.

PMID: 38467935 PMC: 10927889. DOI: 10.1007/s00432-023-05576-3.

Unraveling the Intricacies of Autophagy and Mitophagy: Implications in Cancer Biology.

Lee S, Son J, Lee J, Cheong H Cells. 2023; 12(23).

PMID: 38067169 PMC: 10706449. DOI: 10.3390/cells12232742.

References

Zhu K, Dunner Jr K, McConkey D . Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene. 2009; 29(3):451-62. PMC: 2809784. DOI: 10.1038/onc.2009.343. View

Ward P, Thompson C . Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012; 21(3):297-308. PMC: 3311998. DOI: 10.1016/j.ccr.2012.02.014. View

Kanematsu S, Uehara N, Miki H, Yoshizawa K, Kawanaka A, Yuri T . Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells. Anticancer Res. 2010; 30(9):3381-90. View

Kroemer G, Levine B . Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol. 2008; 9(12):1004-10. PMC: 2727358. DOI: 10.1038/nrm2529. View

Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z . Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci U S A. 2010; 107(16):7455-60. PMC: 2867677. DOI: 10.1073/pnas.1001006107. View

Fantin V, St-Pierre J, Leder P . Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006; 9(6):425-34. DOI: 10.1016/j.ccr.2006.04.023. View

Maclean K, Dorsey F, Cleveland J, Kastan M . Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J Clin Invest. 2007; 118(1):79-88. PMC: 2148253. DOI: 10.1172/JCI33700. View

Warburg O, Wind F, Negelein E . THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 2009; 8(6):519-30. PMC: 2140820. DOI: 10.1085/jgp.8.6.519. View

Vander Heiden M, Christofk H, Schuman E, Subtelny A, Sharfi H, Harlow E . Identification of small molecule inhibitors of pyruvate kinase M2. Biochem Pharmacol. 2009; 79(8):1118-24. PMC: 2823991. DOI: 10.1016/j.bcp.2009.12.003. View

10.

Gorzalczany Y, Gilad Y, Amihai D, Hammel I, Sagi-Eisenberg R, Merimsky O . Combining an EGFR directed tyrosine kinase inhibitor with autophagy-inducing drugs: a beneficial strategy to combat non-small cell lung cancer. Cancer Lett. 2011; 310(2):207-15. DOI: 10.1016/j.canlet.2011.07.002. View

11.

Ye J, Mancuso A, Tong X, Ward P, Fan J, Rabinowitz J . Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci U S A. 2012; 109(18):6904-9. PMC: 3345000. DOI: 10.1073/pnas.1204176109. View

12.

Ertmer A, Huber V, Gilch S, Yoshimori T, Erfle V, Duyster J . The anticancer drug imatinib induces cellular autophagy. Leukemia. 2007; 21(5):936-42. DOI: 10.1038/sj.leu.2404606. View

13.

Wang J, Erickson J, Fuji R, Ramachandran S, Gao P, Dinavahi R . Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell. 2010; 18(3):207-19. PMC: 3078749. DOI: 10.1016/j.ccr.2010.08.009. View

14.

Qian W, Liu J, Jin J, Ni W, Xu W . Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. Leuk Res. 2006; 31(3):329-39. DOI: 10.1016/j.leukres.2006.06.021. View

15.

Sheen J, Zoncu R, Kim D, Sabatini D . Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell. 2011; 19(5):613-28. PMC: 3115736. DOI: 10.1016/j.ccr.2011.03.012. View

16.

Yang C, Sudderth J, Dang T, Bachoo R, Bachoo R, McDonald J . Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res. 2009; 69(20):7986-93. PMC: 2764330. DOI: 10.1158/0008-5472.CAN-09-2266. View

17.

Ellis L, Bots M, Lindemann R, Bolden J, Newbold A, Cluse L . The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy. Blood. 2009; 114(2):380-93. PMC: 4580966. DOI: 10.1182/blood-2008-10-182758. View

18.

Opipari Jr A, Tan L, Boitano A, Sorenson D, Aurora A, Liu J . Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res. 2004; 64(2):696-703. DOI: 10.1158/0008-5472.can-03-2404. View

19.

Petiot A, Ogier-Denis E, Blommaart E, Meijer A, Codogno P . Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem. 2000; 275(2):992-8. DOI: 10.1074/jbc.275.2.992. View

20.

Metallo C, Gameiro P, Bell E, Mattaini K, Yang J, Hiller K . Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature. 2011; 481(7381):380-4. PMC: 3710581. DOI: 10.1038/nature10602. View